BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 23236466)

  • 21. Bone resorption and response to calcium-regulating hormones in the absence of tissue or urokinase plasminogen activator or of their type 1 inhibitor.
    Leloup G; Lemoine P; Carmeliet P; Vaes G
    J Bone Miner Res; 1996 Aug; 11(8):1146-57. PubMed ID: 8854251
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice.
    Piguet PF; Da Laperrousaz C; Vesin C; Tacchini-Cottier F; Senaldi G; Grau GE
    Infect Immun; 2000 Jul; 68(7):3822-9. PubMed ID: 10858190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Receptor-independent role of the urokinase-type plasminogen activator during arteriogenesis.
    Deindl E; Ziegelhöffer T; Kanse SM; Fernandez B; Neubauer E; Carmeliet P; Preissner KT; Schaper W
    FASEB J; 2003 Jun; 17(9):1174-6. PubMed ID: 12692088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin surge-induced up-regulation of the plasminogen activators (tissue plasminogen activator and urokinase plasminogen activator) and the urokinase plasminogen activator receptor within bovine periovulatory follicular and luteal tissue.
    Dow MP; Bakke LJ; Cassar CA; Peters MW; Pursley JR; Smith GW
    Biol Reprod; 2002 May; 66(5):1413-21. PubMed ID: 11967205
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polyoma middle T-induced vascular tumor formation: the role of the plasminogen activator/plasmin system.
    Sabapathy KT; Pepper MS; Kiefer F; Möhle-Steinlein U; Tacchini-Cottier F; Fetka I; Breier G; Risau W; Carmeliet P; Montesano R; Wagner EF
    J Cell Biol; 1997 May; 137(4):953-63. PubMed ID: 9151696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular smooth muscle cells potentiate plasmin generation by both urokinase and tissue plasminogen activator-dependent mechanisms: evidence for a specific tissue-type plasminogen activator receptor on these cells.
    Ellis V; Whawell SA
    Blood; 1997 Sep; 90(6):2312-22. PubMed ID: 9310482
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo.
    Lluís F; Roma J; Suelves M; Parra M; Aniorte G; Gallardo E; Illa I; Rodríguez L; Hughes SM; Carmeliet P; Roig M; Muñoz-Cánoves P
    Blood; 2001 Mar; 97(6):1703-11. PubMed ID: 11238111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.
    Shireman PK; McCarthy WJ; Pearce WH; Shively VP; Cipollone M; Kwaan HC
    J Vasc Surg; 1997 Jan; 25(1):157-64. PubMed ID: 9013920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasminogen activation in healing human wounds.
    Schäfer BM; Maier K; Eickhoff U; Todd RF; Kramer MD
    Am J Pathol; 1994 Jun; 144(6):1269-80. PubMed ID: 8203466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue-type plasminogen activator (tPA) interacts with urokinase-type plasminogen activator (uPA) via tPA's lysine binding site. An explanation of the poor fibrin affinity of recombinant tPA/uPA chimeric molecules.
    Novokhatny V; Medved L; Lijnen HR; Ingham K
    J Biol Chem; 1995 Apr; 270(15):8680-5. PubMed ID: 7721771
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urokinase-type plasminogen activator deficiency has little effect on seizure susceptibility and acquired epilepsy phenotype but reduces spontaneous exploration in mice.
    Rantala J; Kemppainen S; Ndode-Ekane XE; Lahtinen L; Bolkvadze T; Gurevicius K; Tanila H; Pitkänen A
    Epilepsy Behav; 2015 Jan; 42():117-28. PubMed ID: 25506794
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A high-affinity receptor for urokinase plasminogen activator on human keratinocytes: characterization and potential modulation during migration.
    McNeill H; Jensen PJ
    Cell Regul; 1990 Oct; 1(11):843-52. PubMed ID: 1965151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential expression of urokinase-type plasminogen activator (uPA), its receptor (uPA-R), and inhibitor type-2 (PAI-2) during differentiation of keratinocytes in an organotypic coculture system.
    Schaefer BM; Stark HJ; Fusenig NE; Todd RF; Kramer MD
    Exp Cell Res; 1995 Oct; 220(2):415-23. PubMed ID: 7556451
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydrocortisone regulates the dynamics of plasminogen activator and plasminogen activator inhibitor expression in cultured murine keratinocytes.
    Bator JM; Cohen RL; Chambers DA
    Exp Cell Res; 1998 Jul; 242(1):110-9. PubMed ID: 9665808
    [TBL] [Abstract][Full Text] [Related]  

  • 36. uPA-mediated plasminogen activation is enhanced by polyphosphate.
    Whyte CS; Mutch NJ
    Haematologica; 2021 Feb; 106(2):522-531. PubMed ID: 32029503
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pathogenesis of corneal epithelial defects: role of plasminogen activator.
    Hayashi K; Berman M; Smith D; el-Ghatit A; Pease S; Kenyon KR
    Curr Eye Res; 1991 May; 10(5):381-98. PubMed ID: 1909616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.
    Kawao N; Tamura Y; Horiuchi Y; Okumoto K; Yano M; Okada K; Matsuo O; Kaji H
    PLoS One; 2015; 10(4):e0123982. PubMed ID: 25893677
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endogenous plasminogen activators mediate progressive intracerebral hemorrhage after traumatic brain injury in mice.
    Hijazi N; Abu Fanne R; Abramovitch R; Yarovoi S; Higazi M; Abdeen S; Basheer M; Maraga E; Cines DB; Higazi AA
    Blood; 2015 Apr; 125(16):2558-67. PubMed ID: 25673638
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasmin activity is required for myogenesis in vitro and skeletal muscle regeneration in vivo.
    Suelves M; López-Alemany R; Lluís F; Aniorte G; Serrano E; Parra M; Carmeliet P; Muñoz-Cánoves P
    Blood; 2002 Apr; 99(8):2835-44. PubMed ID: 11929773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.